Daraxonrasib doubles survival — a RAS‑targeting drug development breakthrough.
A large study found that women taking GLP-1 drugs, the medication class behind Ozempic, Wegovy, Mounjaro, and Zepbound, were ...
For decades, pancreatic cancer has been one of the most lethal cancers, with few effective treatment options. A new drug, daraxonrasib, targets the KRAS mutation that fuels most pancreatic ...
Onlymyhealth on MSN
What is targeted therapy? A precise approach to cancer treatment
A lot has changed about the cancer treatment methods over the past few years. Doctors are increasingly paying attention to personalized medicine. And targeted therapy is one of the breakthroughs in ...
A new editorial was published in Oncotarget, Volume 16, on March 10, 2025, titled "EXPOSOMES and GENES: The duo influencing CANCER initiation and progression." In this editorial, Drs. Uzma Saqib, ...
A new study found that GLP-1 drugs lowered the risk of breast cancer by about 30%. The effect may be related to the metabolic ...
The gut microbiome plays a crucial role in cancer development and progression, by influencing the host immune system and metabolism. Dysbiosis, or a disruption in the balance of the host gut ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results